This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

APRI 21

Starting date:
April 3, 2013
Posting date:
April 23, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-26851

Recalled Products

  1. APRI 21

Reason

Impurity identified as N-Butylbenzenesulfonamide (NBBS) detected during stability testing of the product.

Depth of distribution

Wholesalers/Distributors and Retail/Pharmacy in all provinces and Nunavut

Affected products

A. APRI 21

DIN, NPN, DIN-HIM
DIN 02317192
Dosage form
  • Film Coated Tablet
Strength
  • 150 mcg / 30 mcg
Lot or serial number
  • 33802977A
  • 33802976A
Companies
Recalling Firm
Apotex Inc.
4100 Weston Road
Toronto
M9L 2Y6
Ontario
CANADA
Marketing Authorization Holder
Barr Laboratoires Inc.
223 Quaker Road
Pomona
10970-0519
New York
UNITED STATES

Date modified: